68 related articles for article (PubMed ID: 3298621)
41. Interaction of platelets with the vessel wall in the pathophysiology of sudden cardiac death.
Hammon JW; Oates JA
Circulation; 1986 Feb; 73(2):224-6. PubMed ID: 3510761
[TBL] [Abstract][Full Text] [Related]
42. Dazoxiben, UK 38,485 and aspirin: duration of effect for preventing thrombotic sudden death in rabbits.
Lindsay LA; Olson RW; Sakane Y; Ghai R; Smith EF
Thromb Res; 1986 Jul; 43(2):177-86. PubMed ID: 3090734
[TBL] [Abstract][Full Text] [Related]
43. The combination of thrombin inhibitor and thromboxane synthase inhibitor on experimental thrombosis and bleeding.
Kawai H; Tamao Y
Thromb Res; 1995 Dec; 80(5):429-34. PubMed ID: 8588204
[No Abstract] [Full Text] [Related]
44. Prostacyclin and prostanoid modifiers aid ischemic skin flap survival.
Knight KR; Kawabata H; Coe SA; Angus JA; O'Brien BM; Sakai K
J Surg Res; 1991 Feb; 50(2):119-23. PubMed ID: 1990215
[TBL] [Abstract][Full Text] [Related]
45. The effects of intravenous prostacyclin in a model of microsurgical thrombosis.
Bailes JE; Quigley MR; Kwaan HC; Nishiura BR; Cerullo LJ; Lastre C
Microsurgery; 1988; 9(1):2-9. PubMed ID: 3292871
[TBL] [Abstract][Full Text] [Related]
46. Uricosuric effect of CGS-12970, a new thromboxane synthase inhibitor.
Saris SD; Piraino AJ; Morgan JM; Hirschhorn WL; Meidl E; Schaffer AV
Clin Pharmacol Ther; 1993 Jul; 54(1):65-9. PubMed ID: 8330466
[TBL] [Abstract][Full Text] [Related]
47. Combined prostacyclin and thromboxane synthetase inhibitor UK 38485 in flap survival.
Zachary LS; Heggers JP; Robson MC; Murphy RC
Ann Plast Surg; 1986 Aug; 17(2):112-5. PubMed ID: 3152454
[TBL] [Abstract][Full Text] [Related]
48. [Thromboxane synthetase inhibitor and prostacyclin analogue].
Nakagawa M; Toyoda T
Nihon Rinsho; 1989 Apr; 47(4):929-34. PubMed ID: 2664267
[No Abstract] [Full Text] [Related]
49. Thromboxane synthesis inhibitor in a beagle pup model of perinatal asphyxia.
Ment LR; Stewart WB; Petroff OA; Duncan CC
Stroke; 1989 Jun; 20(6):809-14. PubMed ID: 2728050
[TBL] [Abstract][Full Text] [Related]
50. Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man.
Sinzinger H; Rauscha F; O'Grady J; Fitscha P
Br J Clin Pharmacol; 1992 Mar; 33(3):289-92. PubMed ID: 1576049
[TBL] [Abstract][Full Text] [Related]
51. Response of the rabbit cutaneous microcirculation to prostanoid modifiers as determined by laser Doppler flowmetry.
Knight KR; Collopy PA; O'Brien BM
Microvasc Res; 1986 Mar; 31(2):197-202. PubMed ID: 3517597
[TBL] [Abstract][Full Text] [Related]
52. Novel oral prostacyclin analog with thromboxane synthase inhibitory activity for management of pulmonary arterial hypertension.
Tran QK; Watanabe H
Circ J; 2013; 77(8):1994-5. PubMed ID: 23803333
[No Abstract] [Full Text] [Related]
53. Blood partition and protein binding of a new reversible proton pump inhibitor, YH1885.
Han KS; Kim YG; Lee JW; Lee MG
Biopharm Drug Dispos; 1998 Sep; 19(6):413-5. PubMed ID: 9737823
[No Abstract] [Full Text] [Related]
54. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
55. Synergism between a phosphodiesterase inhibitor and modulators of thromboxane formation on thrombin-induced sudden death in rabbits.
Smith EF; Olson RW
Prog Clin Biol Res; 1987; 242():241-6. PubMed ID: 3671385
[No Abstract] [Full Text] [Related]
56. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
Simpson PJ; Smith CB; Rosenthal G; Lucchesi BR
J Pharmacol Exp Ther; 1986 Aug; 238(2):497-501. PubMed ID: 3735129
[TBL] [Abstract][Full Text] [Related]
57. In vivo interaction of prostacyclin with an inhibitor of cyclic nucleotide phosphodiesterase, HL 725.
Darius H; Lefer AM; Leprán I; Smith JB
Br J Pharmacol; 1985 Mar; 84(3):735-41. PubMed ID: 2985163
[TBL] [Abstract][Full Text] [Related]
58. Modulation of vascular thrombosis by products of arachidonic acid metabolism.
Wu KK; Hall ER; Papp A
Clin Physiol Biochem; 1984; 2(2-3):84-90. PubMed ID: 6435930
[TBL] [Abstract][Full Text] [Related]
59. Comparison of the effects of a thromboxane synthase inhibitor or prostacyclin in combination with a phosphodiesterase inhibitor for prevention of experimental thrombosis and sudden death in rabbits.
Smith EF; Egan JW
J Pharmacol Exp Ther; 1987 Jun; 241(3):855-60. PubMed ID: 3298621
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
